ABBV vs QGEN: Which Is the Better Dividend Stock?
As of September 2026, ABBV (AbbVie Inc.) screens as the stronger dividend stock, winning 5 of 7 head-to-head metrics. ABBV offers the higher yield at 2.61%, ABBV has the higher dividend-safety score, and QGEN trades at the larger discount to fair value (+19%).
| Metric | ABBV | QGEN |
|---|---|---|
| Forward yield | 2.61% | 0.80% |
| Annual dividend | $6.92 | $0.35 |
| Payout ratio | 190% | 18% |
| Years of growth | 12 yr | 0 yr |
| 5-yr dividend growth | 6.8% | — |
| 5-yr total return | 130% | -25% |
| Dividend safety score | 80 (A) | 59 (C) |
| Fair value estimate | $221.69 | $51.46 |
| Upside to fair value | -16% | +19% |
| Frequency | quarterly | annual |
| Market cap | $467.7B | $9.2B |
| P/E ratio | 74.6 | 22.5 |
Higher yield
ABBV
2.61%
Safer dividend
ABBV
Grade A
Faster growth
ABBV
6.8%
Better value
QGEN
+19% upside
ABBV vs QGEN — FAQ
Related comparisons
See more dividend stock comparisons · data refreshes daily · for informational purposes only, not investment advice.